New User Fees Set for Foreign Medical Device Manufacturers in China
CFDA registration fees will not be insubstantial: Imported Class II device registrants will be charged about $34,000 for initial registration, while foreign Class III device registrants will have to pay about $49,000 for initial registration. Registration renewals every five years for imported devices will cost registrants $6,500 per renewal. User fees will be charged in addition to in-country testing, clinical trials, authorized representation and translation costs.
A translation of the draft fee table below does not include any potential fees for Class I CFDA record filing or CFDA quality system audits.
| CFDA Medical User Fees | Unit: Chinese Yuan (RMB) | Unit: US Dollars (USD) | |||
| Domestic | Imported | Domestic | Imported | ||
| Class II | Initial Registration | – | 210,900 | – | 33,761 |
| Variation Application | – | 42,000 | – | 6,723 | |
| Renewal (every 5 years) | – | 40,800 | – | 6,531 | |
| Class III | High Risk MD Clinical Trial Approval | 43,200 | 43,200 | 6,915 | 6,915 |
| Initial Registration | 153,600 | 308,800 | 24,588 | 49,433 | |
| Variation Application | 50,400 | 50,400 | 8,068 | 8,068 | |
| Renewal (every 5 years) | 40,800 | 40,800 | 6,531 | 6,531 | |
USD figures are calculated based on 1/30/2015 exchange rate of 1 RMB = 0.16008 USD
Source: Emergo Group
Related Articles
-
The UK MHRA has published “Software and Artificial Intelligence as a Medical Device.” The guidance document assembles previous guidances and regulatory requirements for SaMD and AIaMD devices seeking commercialization in the UK market.
-
“Addressing unmet needs across pediatric populations is critical to advancing children’s health, and we are delighted to once again work with pioneering companies that seek to bridge this care gap."
-
The MDDT program was developed in collaboration with the National Institutes of Health’s (NIH’s) National Institute of Drug Abuse (NIDA), National Institute of Dental Craniofacial Research (NIDCR) and National Cancer Institute (NCI) as a way for the FDA to qualify…
-
More and more, the quality of real-world evidence (RWE)—gathered from remote patient monitoring data, product and disease registry data, and patient feedback—determines whether a medical device is approved and, in some instances, for how long. Yet some medical device manufacturers…
